Novartis AG News Headlines

NVS 
$90.146
*  
0.906
1.02%
Get NVS Alerts
*Delayed - data as of Oct. 24, 2014 12:15 ET  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
In Search of High Dividend Yields (An Industry by Industry Survey)
7/14/2011 3:20:00 AM - Seeking Alpha


Novartis: A Common Sense Approach to Biotech
7/12/2011 3:45:00 PM - Seeking Alpha


Zalicus a Potential Buy Out Target for Pfizer
7/11/2011 2:33:00 PM - Seeking Alpha


8 Dividend Stocks With Particularly Strong Balance Sheets
7/11/2011 8:31:00 AM - Seeking Alpha


5 Undervalued Blue Chips With Above-Average and Growing Yield
7/7/2011 3:40:00 PM - Seeking Alpha


Biotech Clinical Trials Update: Alkermes, Novartis and Pharmasset
7/6/2011 6:14:00 PM - Seeking Alpha


Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
7/5/2011 3:29:00 PM - Seeking Alpha


3 Beaten-Down Blue Chips
7/4/2011 2:37:00 PM - Seeking Alpha


Two High Yield Pharmaceutical Stocks to Buy and Hold for the Next Decade
7/4/2011 8:55:00 AM - Seeking Alpha


Titan Pharmaceuticals Is Back in Play With FDA Questions Resolved
7/4/2011 2:24:00 AM - Seeking Alpha


Zalicus Hits Grand Slam With Novartis
7/1/2011 2:21:00 PM - Seeking Alpha


Big Pharma Faces Trouble as FDA Becomes More Like Its European Counterpart
7/1/2011 9:07:00 AM - Seeking Alpha


Cancer Immunotherapy: A Roundtable Discussion
6/30/2011 12:19:00 PM - Seeking Alpha


3 Model Dividend Stock Portfolios to Consider
6/30/2011 7:50:00 AM - Seeking Alpha


Sector Picks From Daniel Loeb's Third Point LLC
6/28/2011 6:53:00 AM - Seeking Alpha


Merck KGaA Leaves Multiple Sclerosis Field Wide Open for Novartis
6/24/2011 7:29:00 AM - Seeking Alpha


Drug Stocks Remain a Safety Calm in the Economic Storm
6/22/2011 2:05:00 PM - Seeking Alpha


Bruce Berkowitz's 9 Latest Buy Ideas
6/21/2011 7:42:00 AM - Seeking Alpha


What FDA's Delay of Probuphine Trial Means for Titan Pharmaceuticals
6/20/2011 8:48:00 AM - Seeking Alpha


8 Potential Biotech Acquisition Candidates
6/19/2011 1:30:00 PM - Seeking Alpha


The Dawn of Stem Cell Medicine With Geron and Advanced Cell Technology
6/15/2011 4:01:00 PM - Seeking Alpha


As the Market Dips, It's Time to Look for Biotech Sector Deals
6/12/2011 9:47:00 AM - Seeking Alpha


Heavyweight Contenders: 64 Dividend Stocks With a Decade of Growth, Yielding Over 3%
6/12/2011 7:03:00 AM - Seeking Alpha


ImmunoCellular Therapeutics Ramps Up Value Proposition With Recent Deals
6/7/2011 3:00:00 PM - Seeking Alpha


Monday Options Recap
6/6/2011 3:31:00 PM - Seeking Alpha